Tech Company Financing Transactions

Iomai Funding Round

EW Healthcare Partners, New Enterprise Associates and Domain Associates invested in a $54 million Series C venture round for Iomai. The funding round was announced on 1/3/2003.

Transaction Overview

Company Information

Company Status

Acquired or Merged

Industry

Biopharmaceutical

Mailing Address

20 Firstfield Road
Gaithersburg, MD 20878
USA

Phone

(301) 556-4500

Website

www.iomai.com

Email Address

[email protected]

Overview

Iomai Corporation is a private biopharmaceutical company that has pioneered the delivery of vaccines to the skin through a proprietary technology known as transcutaneous immunization, or TCI. The company has an exclusive, worldwide license to TCI and has confirmed the potential of TCI in multiple clinical trials.

Profile

Social Media

Company News

Facebook

YouTube

Management Team

Title

Name

Email & Social

Chief Executive Officer

Stanley Erck

        

Vice President

Sarah Frech

        

Vice President

Gregory Glenn

        

Vice President

Robert Seid

        

VP - Bus. Development

Kai Chen

        

VP - General Counsel

Russell Wilson

        

VP - Human Resources

Jin Chung

        

VP - Operations

Mervyn Hamer

        

VP - R & D

Larry Ellingsworth

        

VP - Regulatory Affairs

Kimber Poffenberger

        

Browse more venture capital transactions:

Prev: 1/3/2003: TolerRx venture capital transaction
Next: 1/6/2003: Neterion venture capital transaction

Share this article

About Our Venture Capital Transactions Database

We do our best to report on every notable VC transaction. VC investment data records reported here are sourced from news reports and company announcements. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary